The ICU medical director leadership during COVID-19 pandemic

Authors

  • Ariel Modrykamien, MD, FACP, FCCP

DOI:

https://doi.org/10.5055/ajdm.2020.0346

Keywords:

COVID-19, pandemic

Abstract

-

Author Biography

Ariel Modrykamien, MD, FACP, FCCP

Chief, Critical Care Medicine, Pulmonary and Critical Care Division, Baylor University Medical Center; Associate Clinical Professor of Medicine, Texas A&M Health Science Center, Dallas, Texas

References

Sanders JM, Monogue ML, Jodlowski TZ, et al.: Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020; 323(18): 1824-1836. doi:10.1001/jama.2020.6019.

Paules CI, Marston HD, Fauci AS: Coronavirus Infections-More Than Just the Common Cold. JAMA. 2020; 323(8): 707-708. doi:10.1001/jama.2020.0757 .

Rubin EJ, Baden LR, Morrissey S: Audio Interview: What Clinicians Need to Know in Diagnosing and Treating COVID-19. N Engl J Med. 2020; 382(10): e19.

Dow AA, Clark WE, Farmer JC, et al.: Disaster management. Organizations and academic perspective. Crit Care Clin. 1991; 7(2): 257-270.

Donovan AL, Aldrich JM, Gross AK, et al.: Interprofessional Care and Teamwork in the ICU. Crit Care Med. 2018; 46(6): 980-990.

Downloads

Published

04/01/2020

How to Cite

Modrykamien, MD, FACP, FCCP, A. “The ICU Medical Director Leadership During COVID-19 Pandemic”. American Journal of Disaster Medicine, vol. 15, no. 2, Apr. 2020, pp. 141-2, doi:10.5055/ajdm.2020.0346.

Issue

Vol. 15 No. 2 (2020)

Section

From the Field

License

Copyright 2007-2023, Weston Medical Publishing, LLC 
All Rights Reserved

Similar Articles

1 2 3 4 > >> 

You may also start an advanced similarity search for this article.